These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 37739943)

  • 1. Structural insights into FSP1 catalysis and ferroptosis inhibition.
    Lv Y; Liang C; Sun Q; Zhu J; Xu H; Li X; Li YY; Wang Q; Yuan H; Chu B; Zhu D
    Nat Commun; 2023 Sep; 14(1):5933. PubMed ID: 37739943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated chemical and genetic screens unveil FSP1 mechanisms of ferroptosis regulation.
    Nakamura T; Mishima E; Yamada N; Mourão ASD; Trümbach D; Doll S; Wanninger J; Lytton E; Sennhenn P; Nishida Xavier da Silva T; Angeli JPF; Sattler M; Proneth B; Conrad M
    Nat Struct Mol Biol; 2023 Nov; 30(11):1806-1815. PubMed ID: 37957306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase separation of FSP1 promotes ferroptosis.
    Nakamura T; Hipp C; Santos Dias Mourão A; Borggräfe J; Aldrovandi M; Henkelmann B; Wanninger J; Mishima E; Lytton E; Emler D; Proneth B; Sattler M; Conrad M
    Nature; 2023 Jul; 619(7969):371-377. PubMed ID: 37380771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The crystal structure of human ferroptosis suppressive protein 1 in complex with flavin adenine dinucleotide and nicotinamide adenine nucleotide.
    Feng S; Huang X; Tang D; Liu X; Ouyang L; Yang D; Wang K; Liao B; Qi S
    MedComm (2020); 2024 Mar; 5(3):e479. PubMed ID: 38414669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FSP1 is a glutathione-independent ferroptosis suppressor.
    Doll S; Freitas FP; Shah R; Aldrovandi M; da Silva MC; Ingold I; Goya Grocin A; Xavier da Silva TN; Panzilius E; Scheel CH; Mourão A; Buday K; Sato M; Wanninger J; Vignane T; Mohana V; Rehberg M; Flatley A; Schepers A; Kurz A; White D; Sauer M; Sattler M; Tate EW; Schmitz W; Schulze A; O'Donnell V; Proneth B; Popowicz GM; Pratt DA; Angeli JPF; Conrad M
    Nature; 2019 Nov; 575(7784):693-698. PubMed ID: 31634899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis.
    Bersuker K; Hendricks JM; Li Z; Magtanong L; Ford B; Tang PH; Roberts MA; Tong B; Maimone TJ; Zoncu R; Bassik MC; Nomura DK; Dixon SJ; Olzmann JA
    Nature; 2019 Nov; 575(7784):688-692. PubMed ID: 31634900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unleashing Ferroptosis in Human Cancers: Targeting Ferroptosis Suppressor Protein 1 for Overcoming Therapy Resistance.
    Lee J; Roh JL
    Antioxidants (Basel); 2023 Jun; 12(6):. PubMed ID: 37371948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of FSP1: A new strategy for the treatment of tumors (Review).
    Dai Q; Wei X; Zhao J; Zhang D; Luo Y; Yang Y; Xiang Y; Liu X
    Oncol Rep; 2024 Aug; 52(2):. PubMed ID: 38940330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A non-canonical vitamin K cycle is a potent ferroptosis suppressor.
    Mishima E; Ito J; Wu Z; Nakamura T; Wahida A; Doll S; Tonnus W; Nepachalovich P; Eggenhofer E; Aldrovandi M; Henkelmann B; Yamada KI; Wanninger J; Zilka O; Sato E; Feederle R; Hass D; Maida A; Mourão ASD; Linkermann A; Geissler EK; Nakagawa K; Abe T; Fedorova M; Proneth B; Pratt DA; Conrad M
    Nature; 2022 Aug; 608(7924):778-783. PubMed ID: 35922516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FSP1: a key regulator of ferroptosis.
    Li W; Liang L; Liu S; Yi H; Zhou Y
    Trends Mol Med; 2023 Sep; 29(9):753-764. PubMed ID: 37357101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characterization of AIFM2/FSP1 inhibition by iFSP1-like molecules.
    Xavier da Silva TN; Schulte C; Alves AN; Maric HM; Friedmann Angeli JP
    Cell Death Dis; 2023 Apr; 14(4):281. PubMed ID: 37080964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A targetable CoQ-FSP1 axis drives ferroptosis- and radiation-resistance in KEAP1 inactive lung cancers.
    Koppula P; Lei G; Zhang Y; Yan Y; Mao C; Kondiparthi L; Shi J; Liu X; Horbath A; Das M; Li W; Poyurovsky MV; Olszewski K; Gan B
    Nat Commun; 2022 Apr; 13(1):2206. PubMed ID: 35459868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous regulation of ferroptosis suppressor protein 1 and glutathione peroxidase 4 as a new therapeutic strategy of ferroptosis for esophageal squamous cell carcinoma.
    Miyauchi W; Shishido Y; Matsumi Y; Matsunaga T; Makinoya M; Shimizu S; Miyatani K; Sakamoto T; Umekita Y; Hasegawa T; Fujiwara Y
    Esophagus; 2023 Jul; 20(3):492-501. PubMed ID: 36576648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of structurally diverse FSP1 inhibitors that sensitize cancer cells to ferroptosis.
    Hendricks JM; Doubravsky CE; Wehri E; Li Z; Roberts MA; Deol KK; Lange M; Lasheras-Otero I; Momper JD; Dixon SJ; Bersuker K; Schaletzky J; Olzmann JA
    Cell Chem Biol; 2023 Sep; 30(9):1090-1103.e7. PubMed ID: 37178691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute lymphoblastic leukemia necessitates GSH-dependent ferroptosis defenses to overcome FSP1-epigenetic silencing.
    Pontel LB; Bueno-Costa A; Morellato AE; Carvalho Santos J; Roué G; Esteller M
    Redox Biol; 2022 Sep; 55():102408. PubMed ID: 35944469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. YTHDC1 as a tumor progression suppressor through modulating FSP1-dependent ferroptosis suppression in lung cancer.
    Yuan S; Xi S; Weng H; Guo MM; Zhang JH; Yu ZP; Zhang H; Yu Z; Xing Z; Liu MY; Ming DJ; Sah RK; Zhou Y; Li G; Zeng T; Hong X; Li Y; Zeng XT; Hu H
    Cell Death Differ; 2023 Dec; 30(12):2477-2490. PubMed ID: 37903990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HDLBP-stabilized lncFAL inhibits ferroptosis vulnerability by diminishing Trim69-dependent FSP1 degradation in hepatocellular carcinoma.
    Yuan J; Lv T; Yang J; Wu Z; Yan L; Yang J; Shi Y
    Redox Biol; 2022 Dec; 58():102546. PubMed ID: 36423520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural studies on flavin reductase PheA2 reveal binding of NAD in an unusual folded conformation and support novel mechanism of action.
    van den Heuvel RH; Westphal AH; Heck AJ; Walsh MA; Rovida S; van Berkel WJ; Mattevi A
    J Biol Chem; 2004 Mar; 279(13):12860-7. PubMed ID: 14703520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumin Induces Ferroptosis in A549 CD133
    Zhou J; Zhang L; Yan J; Hou A; Sui W; Sun M
    Discov Med; 2023 Jun; 35(176):251-263. PubMed ID: 37272092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structure of human dihydrolipoamide dehydrogenase: NAD+/NADH binding and the structural basis of disease-causing mutations.
    Brautigam CA; Chuang JL; Tomchick DR; Machius M; Chuang DT
    J Mol Biol; 2005 Jul; 350(3):543-52. PubMed ID: 15946682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.